Experimental evidence gathered from murine tumor models and patient specimen indicates that STK24 deficiency in tumor cells suppresses tumor growth by orchestrating infiltration of activated CD8+ T cells and NK cells. The gene discussed is CD8A; the disease is neoplasm.